NCT00390845 - P38 Mitogen-activated Protein (Map) Kinase Inhibitor (SB-681323)Study In Patients With Neuropathic Pain | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 30, 2006

Primary Completion Date

August 11, 2008

Study Completion Date

August 11, 2008

Conditions

Pain, Neuropathic

Interventions

DRUG

SB681323

15 milligrams (mg)/day

DRUG

Placebo

Trial Locations (13)

GSK Investigational Site, Randwick

GSK Investigational Site, Broadmeadow

GSK Investigational Site, Hanover

GSK Investigational Site, Bochum

GSK Investigational Site, Cologne

GSK Investigational Site, Würzburg

GSK Investigational Site, Moscow

GSK Investigational Site, Cambridge

GSK Investigational Site, Glasgow

GSK Investigational Site, Solihull

GSK Investigational Site, Liverpool

GSK Investigational Site, London

GSK Investigational Site, London